Multiple Choice
A mutant B cell line is examined by confocal microscopy after incubation with a microbial pathogen recognized by the BCR on these B cells. The B cells have been stained with antibodies to visualize the localization of polymerized actin and microtubules. As a control, wild-type B cells are examined. The results are shown in Figure, with the numbers indicating the proportion of cells examined that show each pattern of staining.
To identify the specific signaling defect in these mutant B cells, a reasonable biochemical assay would be to:
A) Determine if BCR stimulation of mutant B cells produces enhanced binding of the B cell to the microbe
B) Determine whether the mutant B cells have reduced levels of the enzyme Protein kinase C-
C) Determine whether the mutant B cells are overexpressing the enzyme Vav
D) Determine whether BCR stimulation of mutant B cells promotes exchange of GDP for GTP on cdc42
E) Determine whether BCR stimulation of mutant B cells produces increased levels of DAG
Correct Answer:

Verified
Correct Answer:
Verified
Q32: Diacyl-glycerol (DAG) is one of the
Q33: Antigen receptor signaling pathways are initiated
Q34: Following TCR stimulation, the small GTPase Ras
Q35: A new strain of immunodeficient mice
Q36: Wiskott-Aldrich syndrome is an immunodeficiency disease due
Q37: The B cell co-receptor, composed of
Q38: BCR stimulation and TCR stimulation generally activate
Q40: Many receptors of the immune system activate
Q41: Following TCR or BCR signaling, the most
Q42: 'Checkpoint blockade' is a therapeutic strategy based